Sustained Release of Antimicrobial Peptide from Self-Assembling Hydrogel Enhanced Osteogenesis

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Infectious Diseases

Background:

• Biomaterials are crucial for treating bone infections like osteomyelitis, primarily caused by bacteria.
• Cationic antimicrobial peptides (AMPs) exhibit broad-spectrum antimicrobial activity but have limited use in bone infections.
• Developing materials that simultaneously address infection and promote bone healing is essential for osteomyelitis treatment.

Purpose of the Study:

• To design and evaluate a novel self-assembling hydrogel for treating bone infections and enhancing osteogenesis.
• To investigate the sustained release of antimicrobial peptides (AMPs) from a RADA16 peptide-based hydrogel.
• To assess the in vitro and in vivo efficacy of the RADA16-AMP hydrogel against Staphylococcus aureus and for bone regeneration.

Main Methods:

• Fabrication of a RADA16 self-assembling peptide hydrogel for AMP delivery.
• Characterization of hydrogel morphology using field emission scanning electron microscopy.
• In vitro studies on bone mesenchymal stem cell (BMSC) proliferation and S. aureus inhibition.
• In vivo evaluation of the hydrogel's efficacy in bone formation.

Main Results:

• The RADA16-AMP hydrogel demonstrated a stable structure with interwoven nanofiber morphology.
• Sustained release of AMPs from the hydrogel was observed for up to 28 days.
• In vitro results showed significant inhibition of S. aureus growth and enhanced BMSC proliferation.
• In vivo studies confirmed the hydrogel's positive effect on bone formation.

Conclusions:

• The developed RADA16-AMP self-assembling hydrogel effectively inhibits bacterial growth and promotes osteogenesis.
• This biomaterial offers a dual-action therapeutic strategy for bone infections and osteomyelitis.
• The findings provide a foundation for applying this novel hydrogel in treating bone-related conditions and advance biomaterial development.